Literature DB >> 25240173

A universal homogeneous assay for high-throughput determination of binding kinetics.

Felix Schiele1, Pelin Ayaz2, Amaury Fernández-Montalván3.   

Abstract

There is an increasing demand for assay technologies that enable accurate, cost-effective, and high-throughput measurements of drug-target association and dissociation rates. Here we introduce a universal homogeneous kinetic probe competition assay (kPCA) that meets these requirements. The time-resolved fluorescence energy transfer (TR-FRET) procedure combines the versatility of radioligand binding assays with the advantages of homogeneous nonradioactive techniques while approaching the time resolution of surface plasmon resonance (SPR) and related biosensors. We show application of kPCA for three important target classes: enzymes, protein-protein interactions, and G protein-coupled receptors (GPCRs). This method is capable of supporting early stages of drug discovery with large amounts of kinetic information.
Copyright © 2014 Elsevier Inc. All rights reserved.

Keywords:  Binding kinetics; High throughput; Probe competition; TR–FRET

Mesh:

Substances:

Year:  2014        PMID: 25240173     DOI: 10.1016/j.ab.2014.09.007

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  15 in total

Review 1.  The drug-target residence time model: a 10-year retrospective.

Authors:  Robert A Copeland
Journal:  Nat Rev Drug Discov       Date:  2015-12-18       Impact factor: 84.694

Review 2.  On the different experimental manifestations of two-state 'induced-fit' binding of drugs to their cellular targets.

Authors:  Georges Vauquelin; Isabelle Van Liefde; David C Swinney
Journal:  Br J Pharmacol       Date:  2016-03-15       Impact factor: 8.739

3.  Pharmacodynamics: Which trails are your drugs taking?

Authors:  Rumin Zhang
Journal:  Nat Chem Biol       Date:  2015-04-20       Impact factor: 15.040

Review 4.  Biophysics in drug discovery: impact, challenges and opportunities.

Authors:  Jean-Paul Renaud; Chun-Wa Chung; U Helena Danielson; Ursula Egner; Michael Hennig; Roderick E Hubbard; Herbert Nar
Journal:  Nat Rev Drug Discov       Date:  2016-08-12       Impact factor: 84.694

Review 5.  Fluorescent ligands: Bringing light to emerging GPCR paradigms.

Authors:  Mark Soave; Stephen J Briddon; Stephen J Hill; Leigh A Stoddart
Journal:  Br J Pharmacol       Date:  2020-02-06       Impact factor: 8.739

6.  The Target Residence Time of Antihistamines Determines Their Antagonism of the G Protein-Coupled Histamine H1 Receptor.

Authors:  Reggie Bosma; Gesa Witt; Lea A I Vaas; Ivana Josimovic; Philip Gribbon; Henry F Vischer; Sheraz Gul; Rob Leurs
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

7.  In vitro and in silico analysis of the effects of D2 receptor antagonist target binding kinetics on the cellular response to fluctuating dopamine concentrations.

Authors:  Wilhelmus E A de Witte; Joost W Versfelt; Maria Kuzikov; Solene Rolland; Victoria Georgi; Philip Gribbon; Sheraz Gul; Dymphy Huntjens; Piet Hein van der Graaf; Meindert Danhof; Amaury Fernández-Montalván; Gesa Witt; Elizabeth C M de Lange
Journal:  Br J Pharmacol       Date:  2018-09-21       Impact factor: 8.739

8.  Development of novel fluorescent histamine H1-receptor antagonists to study ligand-binding kinetics in living cells.

Authors:  Leigh A Stoddart; Andrea J Vernall; Monica Bouzo-Lorenzo; Reggie Bosma; Albert J Kooistra; Chris de Graaf; Henry F Vischer; Rob Leurs; Stephen J Briddon; Barrie Kellam; Stephen J Hill
Journal:  Sci Rep       Date:  2018-01-25       Impact factor: 4.379

9.  A two-state model for the kinetics of competitive radioligand binding.

Authors:  Dong Guo; Lambertus A Peletier; Lloyd Bridge; Wesley Keur; Henk de Vries; Annelien Zweemer; Laura H Heitman; Adriaan P IJzerman
Journal:  Br J Pharmacol       Date:  2018-04-17       Impact factor: 8.739

10.  From receptor binding kinetics to signal transduction; a missing link in predicting in vivo drug-action.

Authors:  Indira Nederpelt; Maria Kuzikov; Wilbert E A de Witte; Patrick Schnider; Bruno Tuijt; Sheraz Gul; Adriaan P IJzerman; Elizabeth C M de Lange; Laura H Heitman
Journal:  Sci Rep       Date:  2017-10-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.